The store will not work correctly when cookies are disabled.
2-(4-(2-(5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-ylthio)ethoxy)benzylidene)malononitrile
ID: ALA2296207
PubChem CID: 76331223
Max Phase: Preclinical
Molecular Formula: C21H16N4O3S
Molecular Weight: 404.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(-c2nnc(SCCOc3ccc(C=C(C#N)C#N)cc3)o2)c1
Standard InChI: InChI=1S/C21H16N4O3S/c1-26-19-4-2-3-17(12-19)20-24-25-21(28-20)29-10-9-27-18-7-5-15(6-8-18)11-16(13-22)14-23/h2-8,11-12H,9-10H2,1H3
Standard InChI Key: IVITYJDOIYZMRR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
4.5275 -9.1556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3429 -9.1568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7498 -8.4523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3425 -7.7462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5239 -7.7490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1207 -8.4541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5670 -8.4525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0464 -9.1109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8246 -8.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8235 -8.0401 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0447 -7.7896 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5404 -9.2526 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.2399 -8.8301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2238 -8.0131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9234 -7.5907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6390 -7.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6497 -8.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3644 -9.1947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0649 -8.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0462 -7.9510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3309 -7.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7811 -9.1659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4801 -8.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1962 -9.1362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4629 -7.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4490 -7.1129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9090 -9.5299 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1127 -7.0428 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5186 -6.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
8 9 1 0
7 8 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 2 0
23 24 1 0
23 25 1 0
25 26 3 0
24 27 3 0
5 28 1 0
28 29 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.45 | Molecular Weight (Monoisotopic): 404.0943 | AlogP: 4.35 | #Rotatable Bonds: 8 |
Polar Surface Area: 104.96 | Molecular Species: NEUTRAL | HBA: 8 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.72 | CX LogD: 3.72 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.31 | Np Likeness Score: -1.71 |
References
1. Deora GS, Karthikeyan C, Moorthy NSHN, Rathore V, Rawat AK, Tamrakar AK, Srivastava AK, Trivedi P. (2013) Design, synthesis and biological evaluation of novel arylidine-malononitrile derivatives as non-carboxylic inhibitors of protein tyrosine phosphatase 1B, 22 (11): [10.1007/s00044-013-0528-1] |